C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/519 (2006.01)
Patent
CA 2410232
The invention relates to (-)-5-(3-Chlorophenyl)-.alpha.-(4-chlorophenyl)- .alpha.-(1-methyl-1H-imidazol-5-yl)tetrazolo-[1,5-a]quinazoline-7-methanamine and its pharmaceutically acceptable acid addition salts, and the use of such compounds in medicine especially for the treatment of cancer.
L'invention concerne une (-)-5-(3-Chlorophényl)-.alpha.-(4-chlorophényl)-.alpha.-(1-méthyl-1<i>H</i>-imidazol-5-yl)tétrazolo-[1,5-a]quinazoline-7-méthanamine et ses sels d'addition d'acide pharmaceutiquement acceptables. L'invention traite également de l'utilisation de ces composés en médecine particulièrement pour le traitement du cancer.
Angibaud Patrick Rene
End David William
Venet Marc Gaston
Gowling Lafleur Henderson Llp
Janssen Pharmaceutica N.v.
LandOfFree
Farnesyl transferase inhibiting 1,2-annelated quinoline... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Farnesyl transferase inhibiting 1,2-annelated quinoline..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Farnesyl transferase inhibiting 1,2-annelated quinoline... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1844643